Syncom formulation share price

Als u op ' Alles accepteren' klikt, gebruiken wij en • gepersonaliseerde advertenties en content weergeven op basis van interesseprofielen • de effectiviteit meten van gepersonaliseerde advertenties en content, en • onze producten en services ontwikkelen en verbeteren Als u niet wilt dat wij en onze partners cookies en persoonsgegevens voor deze aanvullende doeleinden gebruiken, klik dan op ' Alles weigeren'. Als u uw keuzes wilt aanpassen, klik dan op ' Privacyinstellingen beheren'. Je kunt je keuzes te allen tijde wijzigen door te klikken op de links 'Privacy- en cookie-instellingen' of 'Privacydashboard' op onze sites en in onze apps. Lees ons

Syncom Formulations (India) Ltd.: Share Price, Stock Analysis, Annual Report | Value Research Syncom Formulations (India) Ltd.: Share Price, Stock Analysis, Annual Report | Value Research https://www.valueresearchonline.com/stocks/44751/syncom-formulations-india-ltd/ Get Syncom Formulations (India) Ltd.'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house. Business Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India. It offers various products, including generics, alpha adrenoceptor agonists, analgesics, antipyretics, anti-inflammatory, anti-ulcer agents, antibiotics, antidepressants, antifungals, antihistamines, antimalarial, antiplatelet agents, antiprotozoal, antivirals, bronchodilators, calcium antagonists, cardiac medicines, central nervous stimulants, cephelo sporins, cortico steroids, estrogen, cough suppressants, erectile dysfunction, and electrolite. The company also provides histamines, homeostatic, hypoglycemic, hypolipidaemics, local anesthetics, multivitamins and nutritional supplements, sedative anticonvulsants, stimulants, and sympathomimetic products, as well as products used in the treatment of gout. In addition, it engages in the trading of commodities and renting of properties. Further, the company exports its products. It offers its pharmaceutical formulations products in various dosage forms, such as tablets, capsules, liqui...

STOCK SUMMARY • Face Value (₹) 1.00 • Beta 0.31 • 52-Week Low (₹) 4.60 • 52-Week High (₹) 11.60 • Price-to-Book (X)* 2.92 • Dividend Yield (%) 0.00 • Price-to-Earnings (P/E) (X)* 37.90 • Earnings Per Share (₹) 0.21 • Sector Price Earning (X)* 30.49 • Market Cap (₹ Cr.)* 747.30 • * Vaues as of last close price The peers of Syncom Formulations (India) Ltd are Divis Laboratories Ltd, Laurus Labs Ltd, Biocon Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Alkem Laboratories Ltd, Aurobindo Pharma Ltd, Sun Pharmaceuticals Industries Ltd, Glaxosmithkline Pharmaceuticals Ltd, Zydus Lifesciences Ltd, Syngene International Ltd, Dr Reddys Laboratories Ltd, Ajanta Pharma Ltd, Lupin Ltd. Syncom Formulations (India) Ltd, incorporated in the year 1988, has its registered office in 7 Niraj Indl Estate Andheri(E), Off Mahakali Caves Rd, Mumbai, Maharashtra, 400093, 91-22-30887744, 91-22-30887755. The main industry in which Syncom Formulations (India) Ltd operates is Pharmaceuticals - Indian - Formulations. Auditor/Auditors for Syncom Formulations (India) Ltd is/are Sanjay Mehta & Associates. In the main management, Kedarmal Bankda is chairman and Vaishali Agrawal is the company secretary for Syncom Formulations (India) Ltd. • KB Kedarmal Bankda Chairman & Wholetime Director • VSB Vijay Shankarlal Bankda Managing Director • VKK Vinod Kumar Kabra Independent Director • KDN Krishna Das Neema Independent Director • PJ Praveen Jindal Independent Director • RB Rinki Bankda Whole-time Director • RJ ...

Klicken Sie auf „ Alle akzeptieren“, verwenden wir und • personalisierte Werbung und Inhalte auf der Grundlage von Interessenprofilen anzuzeigen • die Effektivität von personalisierten Anzeigen und Inhalten zu messen, sowie • unsere Produkte und Dienstleistungen zu entwickeln und zu verbessern Klicken Sie auf „ Alle ablehnen“, wenn Sie nicht möchten, dass wir und unsere Partner Cookies und personenbezogene Daten für diese zusätzlichen Zwecke verwenden. Wenn Sie Ihre Auswahl anpassen möchten, klicken Sie auf „ Datenschutzeinstellungen verwalten“. Sie können Ihre Einstellungen jederzeit ändern, indem Sie auf unseren Websites und Apps auf den Link „Datenschutz- und Cookie-Einstellungen“ oder „Datenschutz-Dashboard“ klicken. Weitere Informationen darüber, wie wir Ihre personenbezogenen Daten nutzen, finden Sie in unserer

Date Open High Low Close Volume 16/06/2023 7.95 8.20 7.85 7.95 2518452 15/06/2023 8.10 8.25 7.80 7.95 2635032 14/06/2023 8.10 8.30 7.95 7.95 2285619 13/06/2023 7.85 8.30 7.75 7.95 4935497 12/06/2023 7.65 7.85 7.45 7.70 2449654 09/06/2023 7.65 7.75 7.40 7.40 1333171 08/06/2023 7.80 7.95 7.50 7.55 3061523 07/06/2023 7.05 7.70 6.95 7.60 4686553 06/06/2023 7.15 7.15 7.00 7.05 1039518 05/06/2023 6.90 7.10 6.80 7.05 2221285 02/06/2023 6.75 6.90 6.60 6.75 1711133 01/06/2023 6.85 6.95 6.60 6.65 1700846 31/05/2023 7.05 7.25 6.80 6.85 1876548 30/05/2023 7.00 7.45 6.85 7.05 4216555 29/05/2023 6.35 6.60 6.30 6.45 1462282 26/05/2023 6.35 6.45 6.25 6.30 1281615 25/05/2023 6.40 6.55 6.30 6.35 825201 24/05/2023 6.45 6.50 6.30 6.40 1123709 23/05/2023 6.60 6.60 6.35 6.40 900059 22/05/2023 6.50 6.75 6.45 6.50 1247997 19/05/2023 6.50 6.60 6.35 6.50 1111042 18/05/2023 6.50 6.60 6.35 6.40 720241 Date Sources:Live BSE and NSE Quotes Service: TickerPlant | Corporate Data, F&O Data & Historical price volume data: Dion Global Solutions Ltd. BSE Quotes and Sensex are real-time and licensed from the Bombay Stock Exchange. NSE Quotes and Nifty are also real time and licenced from National Stock Exchange. All times stamps are reflecting IST (Indian Standard Time). By using this site, you agree to the Terms of Service and Privacy Policy.

Date Open High Low Close Volume 16/06/2023 7.95 8.20 7.85 7.95 2518452 15/06/2023 8.10 8.25 7.80 7.95 2635032 14/06/2023 8.10 8.30 7.95 7.95 2285619 13/06/2023 7.85 8.30 7.75 7.95 4935497 12/06/2023 7.65 7.85 7.45 7.70 2449654 09/06/2023 7.65 7.75 7.40 7.40 1333171 08/06/2023 7.80 7.95 7.50 7.55 3061523 07/06/2023 7.05 7.70 6.95 7.60 4686553 06/06/2023 7.15 7.15 7.00 7.05 1039518 05/06/2023 6.90 7.10 6.80 7.05 2221285 02/06/2023 6.75 6.90 6.60 6.75 1711133 01/06/2023 6.85 6.95 6.60 6.65 1700846 31/05/2023 7.05 7.25 6.80 6.85 1876548 30/05/2023 7.00 7.45 6.85 7.05 4216555 29/05/2023 6.35 6.60 6.30 6.45 1462282 26/05/2023 6.35 6.45 6.25 6.30 1281615 25/05/2023 6.40 6.55 6.30 6.35 825201 24/05/2023 6.45 6.50 6.30 6.40 1123709 23/05/2023 6.60 6.60 6.35 6.40 900059 22/05/2023 6.50 6.75 6.45 6.50 1247997 19/05/2023 6.50 6.60 6.35 6.50 1111042 18/05/2023 6.50 6.60 6.35 6.40 720241 Date Sources:Live BSE and NSE Quotes Service: TickerPlant | Corporate Data, F&O Data & Historical price volume data: Dion Global Solutions Ltd. BSE Quotes and Sensex are real-time and licensed from the Bombay Stock Exchange. NSE Quotes and Nifty are also real time and licenced from National Stock Exchange. All times stamps are reflecting IST (Indian Standard Time). By using this site, you agree to the Terms of Service and Privacy Policy.

STOCK SUMMARY • Face Value (₹) 1.00 • Beta 0.31 • 52-Week Low (₹) 4.60 • 52-Week High (₹) 11.60 • Price-to-Book (X)* 2.92 • Dividend Yield (%) 0.00 • Price-to-Earnings (P/E) (X)* 37.90 • Earnings Per Share (₹) 0.21 • Sector Price Earning (X)* 30.49 • Market Cap (₹ Cr.)* 747.30 • * Vaues as of last close price COMPETITORS • Alkem Laboratories ₹3,398.95 4.55 (0.13%) • Cipla ₹1,006.05 7.85 (0.79%) • Zydus Lifesciences ₹551.05 1.90 (0.35%) • Sun Pharmaceuticals Industries ₹992.00 3.60 (0.36%) • Syngene International ₹742.40 -7.25 (0.97%) • Torrent Pharmaceuticals ₹1,858.20 19.00 (1.03%) • Biocon ₹244.90 1.40 (0.57%) The peers of Syncom Formulations (India) Ltd are Alkem Laboratories Ltd, Cipla Ltd, Zydus Lifesciences Ltd, Sun Pharmaceuticals Industries Ltd, Syngene International Ltd, Torrent Pharmaceuticals Ltd, Biocon Ltd, Laurus Labs Ltd, Lupin Ltd, Glaxosmithkline Pharmaceuticals Ltd, Divis Laboratories Ltd, Ajanta Pharma Ltd, Aurobindo Pharma Ltd, Dr Reddys Laboratories Ltd. Syncom Formulations (India) Ltd, incorporated in the year 1988, has its registered office in 7 Niraj Indl Estate Andheri(E), Off Mahakali Caves Rd, Mumbai, Maharashtra, 400093, 91-22-30887744, 91-22-30887755. The main industry in which Syncom Formulations (India) Ltd operates is Pharmaceuticals - Indian - Formulations. Auditor/Auditors for Syncom Formulations (India) Ltd is/are Sanjay Mehta & Associates. In the main management, Kedarmal Bankda is chairman and Vaishali Agrawal is the company secretary f...

Syncom Formulations (India) Ltd.: Share Price, Stock Analysis, Annual Report | Value Research Syncom Formulations (India) Ltd.: Share Price, Stock Analysis, Annual Report | Value Research https://www.valueresearchonline.com/stocks/44751/syncom-formulations-india-ltd/ Get Syncom Formulations (India) Ltd.'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house. Business Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India. It offers various products, including generics, alpha adrenoceptor agonists, analgesics, antipyretics, anti-inflammatory, anti-ulcer agents, antibiotics, antidepressants, antifungals, antihistamines, antimalarial, antiplatelet agents, antiprotozoal, antivirals, bronchodilators, calcium antagonists, cardiac medicines, central nervous stimulants, cephelo sporins, cortico steroids, estrogen, cough suppressants, erectile dysfunction, and electrolite. The company also provides histamines, homeostatic, hypoglycemic, hypolipidaemics, local anesthetics, multivitamins and nutritional supplements, sedative anticonvulsants, stimulants, and sympathomimetic products, as well as products used in the treatment of gout. In addition, it engages in the trading of commodities and renting of properties. Further, the company exports its products. It offers its pharmaceutical formulations products in various dosage forms, such as tablets, capsules, liqui...

Klicken Sie auf „ Alle akzeptieren“, verwenden wir und • personalisierte Werbung und Inhalte auf der Grundlage von Interessenprofilen anzuzeigen • die Effektivität von personalisierten Anzeigen und Inhalten zu messen, sowie • unsere Produkte und Dienstleistungen zu entwickeln und zu verbessern Klicken Sie auf „ Alle ablehnen“, wenn Sie nicht möchten, dass wir und unsere Partner Cookies und personenbezogene Daten für diese zusätzlichen Zwecke verwenden. Wenn Sie Ihre Auswahl anpassen möchten, klicken Sie auf „ Datenschutzeinstellungen verwalten“. Sie können Ihre Einstellungen jederzeit ändern, indem Sie auf unseren Websites und Apps auf den Link „Datenschutz- und Cookie-Einstellungen“ oder „Datenschutz-Dashboard“ klicken. Weitere Informationen darüber, wie wir Ihre personenbezogenen Daten nutzen, finden Sie in unserer